D-arabinopyranose has been researched along with Diabetes Mellitus, Type 2 in 1 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpert, E; Ben Yakir, M; Cerasi, E; Cohen, G; Elgart, A; Gruzman, A; Hoffman, A; Katzhendler, Y; Sandovski, D; Sasson, S; Shamni, O | 1 |
1 other study(ies) available for D-arabinopyranose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Novel D-xylose derivatives stimulate muscle glucose uptake by activating AMP-activated protein kinase alpha.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Drug Design; Enzyme Activation; Glucose; Glucose Transporter Type 4; Humans; Models, Biological; Models, Chemical; Muscles; Rats; Structure-Activity Relationship; Xylose | 2008 |